1. Adcitmer®, a new CD56‐targeting monomethyl auristatin E‐conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. (1st February 2022) Authors: Esnault, C.; Leblond, V.; Martin, C.; Desgranges, A.; Baltus, C.B.; Aubrey, N.; Lakhrif, Z.; Lajoie, L.; Lantier, L.; Clémenceau, B.; Sarma, B.; Schrama, J.; Houben, R.; Schrama, D.; Hesbacher, S.; Gouilleux‐Gruart, V.; Feng, Y.; Dimitrov, D.; Guyétant, S.; Berthon, P. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adcitmer®, a new CD56‐targeting monomethyl auristatin E‐conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. (2nd November 2021) Authors: Esnault, C.; Leblond, V.; Martin, C.; Desgranges, A.; Baltus, C.B.; Aubrey, N.; Lakhrif, Z.; Lajoie, L.; Lantier, L.; Clémenceau, B.; Sarma, B.; Schrama, J.; Houben, R.; Schrama, D.; Hesbacher, S.; Gouilleux‐Gruart, V.; Feng, Y.; Dimitrov, D.; Guyétant, S.; Berthon, P. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗